Informação sobre produto
- Ck-1827452
- Methyl 4-[[2-fluoro-3-[N′-(6-methylpyridin-3-yl)ureido]phenyl]methyl]piperazine-1-carboxylate
- Omecamtiv mecarbil
- 1-Piperazinecarboxylic acid, 4-[[2-fluoro-3-[[[(6-methyl-3-pyridinyl)amino]carbonyl]amino]phenyl]methyl]-, methyl ester
CK 1827452O is a small-molecule drug that increases the glomerular filtration rate (GFR) by inhibiting the Na+,K+-ATPase. CK 1827452O has been shown to be effective in treating congestive heart failure, which may be due to its ability to increase cardiac output and reduce left ventricular end-diastolic pressure. CK 1827452O also acts on the cytosolic calcium concentration and systolic pressure, as well as natriuretic and inotropic drugs. These effects are due to its inhibition of Na+,K+-ATPase, which leads to an increase in intracellular calcium and an increase in cAMP levels.
Propriedades químicas
Consulta técnica sobre: 3D-FC103484 CK 1827452O
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
